Skip to main content
. Author manuscript; available in PMC: 2014 Aug 14.
Published in final edited form as: J Pediatr Hematol Oncol. 2012 Apr;34(3):e114–e116. doi: 10.1097/MPH.0b013e3182331fbe

Table 1.

All patients were treated with VAC (vincristine, actinomycin-D, cyclophosphamide) as per the Children's Oncology Group study D9803 protocol [15]. M: male, F: female, doxo: doxorubicin, cddp: cisplatinum, VTC: vincristine, topotecan, cyclophosphamide, AWED: Alive without evidence of disease

Patient Age at diagnosis (years) Gender Initial surgery Chemotherapy Radiation Current Status Time from therapy
1 4 M Left lateral segment hepatectomy and partial gastrectomy doxo, CDDP × 1 cycle
VAC × 10 cycles
No AWED 204 months
2 12 F Right hepatic lobectomy, cholecystectomy, excision of the cystic duct and right portohepatic lymph nodes VAC × 7 cycles No AWED 100 months
3 13 F Right hepatic lobectomy, nasal biopsy VAC × 14 cycles 66 Gy to nasal ala AWED 53 months
4 13 F Right hepatic lobectomy VAC × 7 cycles No AWED 40 months
5 6 M Left hepatic lobectomy VAC × 11 cycles
VTC × 3 cycles
19.5 Gy to whole abdomen AWED 38 months